{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:11:12Z","timestamp":1790485872588,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/hjh.0b013e328325d831","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T09:09:43Z","timestamp":1242896983000},"page":"886-893","source":"Crossref","is-referenced-by-count":43,"title":["Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study"],"prefix":"10.1097","volume":"27","author":[{"given":"Henry","family":"Krum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Swergold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S","family":"Smugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Laine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Craig","family":"Brater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20210208","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","article-title":"Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis","volume":"121","author":"Johnson","year":"1994","journal-title":"Ann Intern Med"},{"key":"R2-31-20210208","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archinte.165.5.ioi50013","article-title":"Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure","volume":"165","author":"Aw","year":"2005","journal-title":"Arch Intern Med"},{"key":"R3-31-20210208","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2174\/1381612053764922","article-title":"Renal effects of nonsteroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors","volume":"11","author":"Cheng","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R4-31-20210208","doi-asserted-by":"crossref","first-page":"10D","DOI":"10.1016\/S0002-9149(02)02232-4","article-title":"Cyclooxygenase-2 inhibition and renal physiology","volume":"89","author":"Harris","year":"2002","journal-title":"Am J Cardiol"},{"key":"R5-31-20210208","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","article-title":"Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison","volume":"368","author":"Cannon","year":"2006","journal-title":"Lancet"},{"key":"R6-31-20210208","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ahj.2006.05.024","article-title":"Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis","volume":"152","author":"Cannon","year":"2006","journal-title":"Am Heart J"},{"key":"R7-31-20210208","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1524-6175.2003.00514.x","article-title":"The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs","volume":"5","author":"Morgan","year":"2003","journal-title":"J Clin Hypertens"},{"key":"R8-31-20210208","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archinte.1995.00430100075009","article-title":"The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil","volume":"155","author":"Houston","year":"1995","journal-title":"Arch Intern Med"},{"key":"R9-31-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R10-31-20210208","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","article-title":"Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study","volume":"96","author":"Franklin","year":"1997","journal-title":"Circulation"},{"key":"R11-31-20210208","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.0000157159.39889.EC","article-title":"Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study","volume":"111","author":"Franklin","year":"2005","journal-title":"Circulation"},{"key":"R12-31-20210208","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/17425255.1.2.269","article-title":"Clinical pharmacology of etoricoxib","volume":"1","author":"Capone","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R13-31-20210208","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)16894-3","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial","volume":"364","author":"Farkouh","year":"2004","journal-title":"Lancet"},{"key":"R14-31-20210208","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2165\/00003495-198835030-00004","article-title":"Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"35","author":"Todd","year":"1988","journal-title":"Drugs"},{"key":"R15-31-20210208","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"R16-31-20210208","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00004872-200106000-00020","article-title":"Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators","volume":"19","author":"Sever","year":"2001","journal-title":"J Hypertens"},{"key":"R17-31-20210208","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/08037050701217643","article-title":"Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk","volume":"16","author":"Weber","year":"2007","journal-title":"Blood Press"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-200904000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:47Z","timestamp":1786038527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-200904000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328325d831","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}